Hybrid operating room

LIMACORPORATE ANNOUNCES FDA APPROVAL FOR NEW "PRIMA" SHOULDER PLATFORM INCLUDING SHORT STEM AND TT GLENOID

Retrieved on: 
Friday, October 7, 2022
Quality of life, Movement, Efficiency, PRIMA, Patient, 3D, Research, History, Technology, Solution, Company, Innovation Center station, Motion, Extremities, EBM, Elective surgery, Electron-beam additive manufacturing, Shoulder, FDA, Surgeon, Hybrid operating room, 3D printing, Medical imaging, Dentistry

Udine, Italy, Oct. 7, 2022 /PRNewswire/ -- LimaCorporate proudly announces the FDA approval of a new shoulder platform focused on versatility and Operating Room efficiency.

Key Points: 
  • Udine, Italy, Oct. 7, 2022 /PRNewswire/ -- LimaCorporate proudly announces the FDA approval of a new shoulder platform focused on versatility and Operating Room efficiency.
  • The PRIMA system consists of a novel 3D-printed convertible short stem and a fully 3D-printed glenoid replacement for Reverse Shoulder Arthroplasty.
  • PRIMA TT Glenoid was designed with the ambitious goal of empowering surgeons with a complete solution suitable to solve a wide range of glenoid replacement cases in Reverse Shoulder Arthroplasty.
  • Massimo Calafiore LimaCorporate CEO stated "Today's FDA approval for PRIMA TT Glenoid represents an exciting opportunity to accelerate our market growth in key regions.

Med Dimensions Garners "Pet Start Up of the Year" Award In 2022 Pet Independent Innovation Awards Program

Retrieved on: 
Thursday, September 15, 2022
3D, LOS, Food, Entrepreneurship, Anesthesia, MRI, Veterinarian, Pet, Patient, CEO, Hybrid operating room, Solution, Pathology, Arthroscopy, CT, Surgeon, Research, Retail, Fear, Anatomy, Bottled water, Medical imaging, Service, Housing, Health

LOS ANGELES, Sept. 15, 2022 /PRNewswire-PRWeb/ -- The 2022 Pet Independent Innovation Awards, an independent recognition platform highlighting the most innovative companies, services, and products in the highly competitive Pet care industry, today announced that Med Dimensions, a veterinary medical device company specializing in patient-specific education and surgical solutions, has been selected as "Pet Start Up of the Year."

Key Points: 
  • Med Dimensions converts CT scans and high resolution MRI's of pet patients into 3D pre-operative models, and builds patient-specific cutting guides for intraoperative use.
  • "What a thrill it is to be recognized by the Pet Innovation Awards program this year.
  • Part of Independent Innovation Awards organization, a global market intelligence and recognition program within the most competitive consumer categories, The Pet Innovation Awards honors the most outstanding and innovative companies, services, and products within the rapidly expanding pet care industry.
  • By committing ourselves to constant innovation, research and development, Med Dimensions seeks to lead medical 3D modeling.

Charles Huang Foundation Makes Record-Breaking Donation to Methodist Hospital in Arcadia

Retrieved on: 
Tuesday, June 28, 2022
Innova, Fellowship of the Royal Colleges of Surgeons, Neurosurgery, Patient, Asian Pacific American Heritage Month, Elective surgery, HSBC, San Francisco Chinese Hospital, Methodist Hospital, Wuhan University, Multimedia, Consulate, History, BNP Paribas, California State Assembly Republican Caucus, Consulate-General of China, Los Angeles, MHSC, Cardiac catheterization, Comprehensive, University of California, Irvine Medical Center, University, University of Strathclyde, ATL, CHF, Hybrid operating room, California State Assembly, Donation, Obstetrics, City, Percussion section, Foundation, AAPI, Family, American College, Electrophysiology, Bed, TMT, State, Hospital, Pharmaceutical industry, Medical device

PASADENA, Calif., June 27, 2022 /PRNewswire/ -- Chinese American entrepreneur Dr. Charles Huang, the founder of Charles Huang Foundation (CHF), announced a $7.5 million donation to Methodist Hospital of Southern California (MHSC) in Arcadia, the largest ever single gift in its 119-year history. This is the second donation made to hospitals by Dr. Huang's private foundation following the record-breaking gift to 123-year-old San Francisco Chinese Hospital early this month.

Key Points: 
  • PASADENA, Calif., June 27, 2022 /PRNewswire/ -- Chinese American entrepreneur Dr. Charles Huang, the founder of Charles Huang Foundation (CHF), announced a $7.5 million donation to Methodist Hospital of Southern California (MHSC) in Arcadia,the largest ever single gift in its 119-year history.
  • "We are so fortunate and pleased with this generous gift from Dr. Huang," said Mike Driebe, president of the Methodist Hospital Foundation.
  • Most recently, Dr. Huang made a major donation to San Francisco's Chinese Hospital and created the Charles Huang Foundation Research Fund at the University of California, Los Angeles.
  • About Methodist Hospital of Southern California:
    Founded in 1903, Methodist Hospital of Southern California is a full-service community hospital with 348 licensed beds.

ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array™ Version 1.1

Retrieved on: 
Thursday, April 28, 2022
Solution, Surgeon, Business development, U.S. Securities and Exchange Commission, Association, Patient, Paper, Nasdaq, FDA, Particular, GLOBE, COVID-19, Quality of life, Growth, Clinical trial, Hybrid operating room, Company, American Association, Therapy, Hospital, Security (finance), Biopsy, Lists of diseases, Research, Brain, LMR, Robot, Rigidity, Biopharmaceutical, CNS, Medical imaging, Array, Software

SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the Company), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its next generation SmartFrame Array Neuro Navigation System and Software.

Key Points: 
  • SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the Company), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its next generation SmartFrame Array Neuro Navigation System and Software.
  • During the limited release, SmartFrame Array was used in over 50 pre-clinical, clinical trial, and clinical procedures at 10 hospitals and clinical research organizations across North America.
  • The SmartFrame Array will be on display from April 29 May 1 in the ClearPoint Neuro booth at the 2022 American Association of Neurological Surgeons Annual Scientific Meeting in Philadelphia, PA .
  • The ClearPoint Neuro Navigation System has FDA clearance, is CE-marked, and is installed in approximately 60 active sites in the United States, Canada, and Europe.

Global Hybrid Operating Room Market Analysis and Forecast Report 2021-2030: Continued Growth Due to Increasing Demand for Cardiovascular and Neurological Applications - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 27, 2021
Hospitals, Health, Surgery, Cardiology, Medicine, Hybrid operating room, Medical equipment, Health care, Surgery, Urology, Minimally invasive procedure

b'The "Global Hybrid Operating Room Market: Analysis and Forecast, 2021-2030" report has been added to ResearchAndMarkets.com\'s offering.\nThe global hybrid OR market is projected to reach $2.52 billion by 2030.\nThe study highlights that the market is set to witness a CAGR of 11.79% between 2021 and 2030.

Key Points: 
  • b'The "Global Hybrid Operating Room Market: Analysis and Forecast, 2021-2030" report has been added to ResearchAndMarkets.com\'s offering.\nThe global hybrid OR market is projected to reach $2.52 billion by 2030.\nThe study highlights that the market is set to witness a CAGR of 11.79% between 2021 and 2030.
  • The market is expected to continue to grow on the backdrop of increasing demand for cardiovascular and neurological applications.\nAs global healthcare continues its focus on reducing patient recovery time and decreased length of stay in hospitals, hybrid ORs are expected to be adopted across regions.
  • The basic motive for the adoption of hybrid ORs is expected to remain the same as global healthcare increases its preference for minimally invasive surgeries compared to open surgeries.
  • Hybrid ORs enable surgeons to perform both open and minimally invasive procedures.

Carbon Composite Operating Tables Market Size, Impacted by COVID-19, to Reach US$ 367 Million in 2026, Says Stratview Research

Retrieved on: 
Friday, January 29, 2021
Medical equipment, Medicine, Textiles, Health care, Hybrid operating room, Allotropes of carbon, Operating table, Operating theater, Carbon fibers

Operating tables with carbon composite tabletop offer radiolucency which makes them suitable for hybrid operating rooms and diagnostic imaging.

Key Points: 
  • Operating tables with carbon composite tabletop offer radiolucency which makes them suitable for hybrid operating rooms and diagnostic imaging.
  • The outbreak of the COVID-19 pandemic has negatively impacted the carbon composite operating tables market.
  • The market for carbon composite operating tables is expected to recover from 2021 onwards and grow at a healthy pace over the next five years to reach an estimated value of US$ 367 million in 2026.
  • In terms of region, North America accounted for the largest share of the carbon composite operating tables market in 2020.

Carbon Composite Operating Tables Market Size, Impacted by COVID-19, to Reach US$ 367 Million in 2026, Says Stratview Research

Retrieved on: 
Friday, January 29, 2021
Medical equipment, Medicine, Textiles, Health care, Hybrid operating room, Allotropes of carbon, Operating table, Operating theater, Carbon fibers

Operating tables with carbon composite tabletop offer radiolucency which makes them suitable for hybrid operating rooms and diagnostic imaging.

Key Points: 
  • Operating tables with carbon composite tabletop offer radiolucency which makes them suitable for hybrid operating rooms and diagnostic imaging.
  • The outbreak of the COVID-19 pandemic has negatively impacted the carbon composite operating tables market.
  • The market for carbon composite operating tables is expected to recover from 2021 onwards and grow at a healthy pace over the next five years to reach an estimated value of US$ 367 million in 2026.
  • In terms of region, North America accounted for the largest share of the carbon composite operating tables market in 2020.

Fluoroscopy Equipment Market worth $7.5 billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, December 15, 2020
Fluoroscopy, Hybrid operating room

The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market, by product, in 2019.

Key Points: 
  • The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market, by product, in 2019.
  • On the basis of product, the market is segmented into fixed C-arms, fluoroscopy systems, and mobile C-arms.
  • The fixed C-arms segment accounted for the largest share of the market in 2019.
  • On the basis of application, the fluoroscopy equipment market is segmented into diagnostic applications and surgical applications.

Fluoroscopy Equipment Market worth $7.5 billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, December 15, 2020
Fluoroscopy, Hybrid operating room

The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market, by product, in 2019.

Key Points: 
  • The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market, by product, in 2019.
  • On the basis of product, the market is segmented into fixed C-arms, fluoroscopy systems, and mobile C-arms.
  • The fixed C-arms segment accounted for the largest share of the market in 2019.
  • On the basis of application, the fluoroscopy equipment market is segmented into diagnostic applications and surgical applications.

Fujifilm Enters U.S. Surgical C-Arm and Radiographic Fluoroscopy Markets

Retrieved on: 
Thursday, November 19, 2020
Medical physics, Fluoroscopy, Fujifilm, Radiography, Medicine, Medical imaging, Optics, Applied sciences, Hybrid operating room, Jeffrey Siewerdsen

LEXINGTON, Mass., Nov. 19, 2020 /PRNewswire/ -- FUJIFILM Medical Systems U.S.A., Inc ., a leading provider of diagnostic imaging and medical informatics solutions, has entered the surgical and fluoroscopy markets with two new systems: the Persona C Surgical C-Arm and Persona RF PREMIUM System.

Key Points: 
  • LEXINGTON, Mass., Nov. 19, 2020 /PRNewswire/ -- FUJIFILM Medical Systems U.S.A., Inc ., a leading provider of diagnostic imaging and medical informatics solutions, has entered the surgical and fluoroscopy markets with two new systems: the Persona C Surgical C-Arm and Persona RF PREMIUM System.
  • Persona C surgical c-arm is an advanced imaging solution engineered for fast, precise positioning and advanced image quality across a broad range of diagnostic imaging and minimally invasive surgical procedures.
  • It will be available with 21x21cm or 30x30cm amorphous Silicon (aSi) flat panel detector options for ultra-low dose fluoroscopy and vascular imaging.
  • Individuals interested in learning more about the newest c-arm and radiographic fluoroscopy systems can book a virtual demo with Fujifilm by visiting: https://www.infowebpage.com/FujiRSNA2020/
    FUJIFILM Medical Systems U.S.A., Inc .